Literature DB >> 21553154

Association of steroid use with complicated sigmoid diverticulitis: potential role of activated CD68+/CD163+ macrophages.

Burkhard H A von Rahden1, Stefan Kircher, Svenja Thiery, Denise Landmann, Christian F Jurowich, Christoph-Thomas Germer, Martin Grimm.   

Abstract

BACKGROUND: Immunosupression and, especially, intake of steroids have previously been identified as risk factors for complicated types of sigmoid diverticulitis. However, little is known about the underlying molecular and cellular mechanisms. We aimed to elucidate the potential role of activated macrophages in this respect.
METHODS: A consecutive series of n = 101 patients having undergone surgical resection for sigmoid diverticulitis at our institution was analyzed regarding the inflammatory infiltrate and prevalence of comorbid diseases as well as risk factors, including steroid use. Fifty-seven patients had complicated types of diverticulitis with severe inflammation (group A). Forty-four patients had moderate inflammation, most of whom had been operated for chronically recurrent diverticulitis (group B). Randomly selected 50 patients (n = 20/group A/n = 30 group B) underwent immunolabelling against CD68 and CD163.
RESULTS: Using immunofluorescence double labeling experiments we found a strong positive correlation of CD68 expression with CD163 expression (т = 0.934). High CD68 expression (x ≥ 23%) and high CD163 expression (x ≥ 22%) within stromal cells of the lamina propria was significantly associated with steroid use (CD68, p = 0.012 and CD163, p = 0.004, respectively) and complicated sigmoid diverticulitis with severe inflammation (CD68, p = 0.0001 and CD163, p = 0.001, respectively).
CONCLUSIONS: Inflammation, especially mediated by activated (CD68+/CD163+) macrophages in histopathological specimen might resemble the cellular link between steroid use and complicated types of sigmoid diverticulitis. Macrophages might be a suitable target for future supportive/preventive therapies. However, as long as we are lacking such strategies, we must bear in mind that steroid intake is a risk factor for complicated diverticulitis, especially when indicating surgical resection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553154     DOI: 10.1007/s00423-011-0797-4

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  36 in total

1.  Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology.

Authors:  N H Stollman; J B Raskin
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

Review 2.  The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002.

Authors:  Pierre Bourlioux; Berthold Koletzko; Francisco Guarner; Véronique Braesco
Journal:  Am J Clin Nutr       Date:  2003-10       Impact factor: 7.045

3.  Glucocorticoids exert opposing effects on macrophage function dependent on their concentration.

Authors:  Hee-Young Lim; Nora Müller; Marco J Herold; Jens van den Brandt; Holger M Reichardt
Journal:  Immunology       Date:  2007-04-23       Impact factor: 7.397

Review 4.  Clinical practice. Diverticulitis.

Authors:  Danny O Jacobs
Journal:  N Engl J Med       Date:  2007-11-15       Impact factor: 91.245

5.  Complicated diverticulitis: is it time to rethink the rules?

Authors:  Jennifer Chapman; Michael Davies; Bruce Wolff; Eric Dozois; Deron Tessier; Jeffrey Harrington; Dirk Larson
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

Review 6.  Safety of inhaled and intranasal corticosteroids: lessons for the new millennium.

Authors:  B J Lipworth; C M Jackson
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

7.  Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins.

Authors:  C L Holness; D L Simmons
Journal:  Blood       Date:  1993-03-15       Impact factor: 22.113

8.  Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family.

Authors:  C L Holness; R P da Silva; J Fawcett; S Gordon; D L Simmons
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

9.  NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia.

Authors:  Stefan Gattenlöhner; Christiane Waller; Georg Ertl; Burkhard-Dieter Bültmann; Hans-Konrad Müller-Hermelink; Alexander Marx
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

10.  Enhancing versus suppressive effects of stress hormones on skin immune function.

Authors:  F S Dhabhar; B S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

View more
  6 in total

1.  Diverticulitis in immunosuppressed patients: A fatal outcome requiring a new approach?

Authors:  Andreas Brandl; Theresa Kratzer; Reinhold Kafka-Ritsch; Eva Braunwarth; Christian Denecke; Sascha Weiss; Georgi Atanasov; Robert Sucher; Matthias Biebl; Felix Aigner; Johann Pratschke; Robert Öllinger
Journal:  Can J Surg       Date:  2016-08       Impact factor: 2.089

Review 2.  Pathogenesis of colonic diverticular disease.

Authors:  Burkhard H A von Rahden; Christoph-Thomas Germer
Journal:  Langenbecks Arch Surg       Date:  2012-06-20       Impact factor: 3.445

Review 3.  Recent advances in understanding and managing diverticulitis.

Authors:  Carola Severi; Marilia Carabotti; Alessia Cicenia; Lucia Pallotta; Bruno Annibale
Journal:  F1000Res       Date:  2018-06-29

Review 4.  Role of Inflammation in Pathophysiology of Colonic Disease: An Update.

Authors:  Noha Ahmed Nasef; Sunali Mehta
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

5.  A Bioactive Extract Rich in Triterpenic Acid and Polyphenols from Olea europaea Promotes Systemic Immunity and Protects Atlantic Salmon Smolts Against Furunculosis.

Authors:  Ricardo Salomón; M Dolors Furones; Felipe E Reyes-López; Lluis Tort; Joana P Firmino; M Angeles Esteban; Cristóbal Espinosa Ruíz; José C Quintela; José M Pinilla-Rosas; Eva Vallejos-Vidal; Enric Gisbert
Journal:  Front Immunol       Date:  2021-11-12       Impact factor: 7.561

6.  Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.

Authors:  Eleonora Franzè; Roberta Caruso; Carmine Stolfi; Massimiliano Sarra; Maria Laura Cupi; Flavio Caprioli; Ivan Monteleone; Francesca Zorzi; Daniela De Nitto; Alfredo Colantoni; Livia Biancone; Francesco Pallone; Giovanni Monteleone
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.